Today, tiger milk mushroom is gaining global attention, with many brands highlighting new discoveries and claiming “world’s first” breakthroughs.
Yet meaningful scientific innovation is never an overnight success. It is the result of years of rigorous research, careful validation, and continuous refinement.
Behind today’s clinically studied tiger milk mushroom lies more than 20 years of dedicated scientific work that transformed a rare tropical forest mushroom into a standardized, sustainable, and clinically validated functional ingredient.1
This journey spans four critical milestones: controlled cultivation, strain identity and standardization, safety evaluation, biological mechanisms, and human clinical validation.
From rare wild mushroom to reliable functional ingredient
For centuries, the tiger milk mushroom was harvested only from the wild, making supply unpredictable and scientific research nearly impossible. Variations in growing conditions also resulted in inconsistent quality and bioactive composition, limiting its potential for modern healthcare applications.
A major breakthrough came with the successful domestication and indoor cultivation of the mushroom. Researchers established the precise substrate conditions and cultivation protocols needed to produce high-quality sclerotia consistently through controlled cultivation and solid-state fermentation.
Equally important, collaborative research with Universiti Malaya, conducted scientific studies to characterize the bioactive profile of cultivated TM02® Tiger Milk Mushroom. The studies identified glycoproteins, Rhinoprolycan, Rhinocelectin, distinct fungal immunomodulatory proteins, and serine proteases among its characterized bioactive constituents.2,3
These agricultural advances solved longstanding supply chain and quality-control challenges while creating a standardized ingredient suitable for large-scale production. Without this foundation, reliable scientific testing, commercial development, and clinical research would not have been possible.
Why strain identity and standardization matter
Functional mushroom ingredients can vary by species, strain, cultivation, and processing, potentially affecting their bioactive composition and research outcomes. Clearly identifying the strain and maintaining consistent production conditions are therefore important for scientific reproducibility.
TM02® is a cultivated strain of Lignosus rhinocerus that has undergone extensive preclinical and human clinical investigation, supported by controlled cultivation, bioactive characterization, safety evaluation, and standardization.
Importantly, findings from one strain should not automatically be generalized to other strains or products produced using different cultivation and processing methods. Standardization also helps manufacturers assess ingredient specifications, batch consistency, and suitability for product development.
Building the foundation of safety
Before any functional ingredient can be recommended for human use, its safety must be demonstrated through rigorous scientific evaluation rather than assumption.
Over the years, an extensive series of preclinical studies systematically evaluated the safety of the TM02® strain of tiger milk mushroom. These investigations included in vitro and in vivo assessments covering acute, subacute, and chronic toxicity, as well as teratogenicity and genotoxicity.4-5
Together, they established a comprehensive safety profile long before consumers encountered the ingredient in commercial products in various formats. These studies also formed the scientific foundation supporting regulatory submissions and subsequent clinical investigations.
Understanding how it works
Once cultivation and safety had been established, researchers shifted their attention from asking whether TM02® Tiger Milk Mushroom worked to understanding how it worked.
Years of laboratory and preclinical research mapped the biological pathways responsible for its therapeutic potential. Studies demonstrated its ability to influence immune cell activity, regulate cytokine responses, and modulate inflammatory pathways associated with respiratory and immune health.6-7 These mechanistic investigations provided valuable insights into how the mushroom exerts its biological effects at both cellular and systemic levels.
Understanding these mechanisms was essential because it provided the scientific rationale needed for meaningful human clinical trials. Rather than relying solely on traditional knowledge, researchers built a mechanistic evidence base that explained the observed health benefits.
The gold standard: Human clinical validation
Scientific credibility ultimately depends on evidence from well-designed human studies. Building upon years of agricultural, safety, and mechanistic research, TM02® Tiger Milk Mushroom progressed to randomized, double-blind, placebo-controlled clinical trials – the gold standard of medical research.
These peer-reviewed studies evaluated real-world health outcomes across multiple populations, including respiratory health, asthma, allergic rhinitis, and supportive care for breast cancer patients after chemotherapy, as well as topical applications.3,8-10

Clinical trial outcomes at a glance
Asthma and respiratory function: In a randomized trial, 90 days of TM02® supplementation produced a significant improvement in lung function, with trough forced expiratory volume in one second (FEV1) increasing by an average of 0.3 L (p<0.001), alongside better asthma control (lower Asthma Control Questionnaire-7 [ACQ-7] scores) and significant reductions in airway inflammation markers (fractional exhaled nitric oxide [FeNO], blood eosinophils, serum immunoglobulin E [IgE]).8
Allergic rhinitis: A randomized, double-blind, placebo-controlled trial found TM02® significantly improved allergic rhinitis symptoms and disease control compared to placebo, with symptom improvement positively associated with reductions in the inflammatory marker IL-5. The supplement was well tolerated.9
Supportive care in breast cancer remission: In a placebo-controlled trial of 52 patients who had completed surgery and chemotherapy, six months of daily TM02® supplementation produced a significant within-patient improvement in Global Health Status scores, along with a trend toward better physical functioning and reduced fatigue, with a favorable safety profile.9
Physical fitness and exercise performance: In an 8-week randomized, double-blind trial evaluating young males, daily TM02® supplementation demonstrated targeted enhancements in upper-limb muscle performance, producing significant post-intervention gains in shoulder strength and power compared to baseline and control groups.11
Topical application (skin health): A six-week split-site pilot study of a topical TM02® extract (xLr) cream showed a significant reduction in atopic dermatitis severity and itch, with efficacy comparable to 1% hydrocortisone cream and no adverse events reported.
Taken together, these trials span oral and topical delivery, multiple patient populations, and both symptom and biomarker endpoints – demonstrating that the research journey did not end in the laboratory. Instead, they provided human evidence supporting the mushroom’s potential health benefits and represented the culmination of decades of systematic scientific effort.
A legacy built on science
The growing recognition of TM02® Tiger Milk Mushroom today is not the result of recent marketing trends or isolated discoveries. It reflects more than two decades of sustained research that established reliable cultivation methods, demonstrated safety, uncovered biological mechanisms, and achieved human clinical validation.
Every new study builds upon this scientific foundation. Understanding this research legacy provides important context for the innovations emerging today and highlights why rigorous, long-term science remains the cornerstone of developing trusted functional ingredients.
Author: Shin-Yee FUNG, professor of biochemistry, Universiti Malaya; principal investigator and head of the medicinal mushroom research group (MMRG).
References
- Booi, H.-N.; et al. Medicinal mushrooms and their use to strengthen respiratory health during and post-COVID-19 pandemic. International Journal of Medicinal Mushrooms. 2022; 24(11), 1–14.
- Sum, A. Y. C.; et al. The immunomodulating properties of tiger milk medicinal mushroom, Lignosus rhinocerus TM02® cultivar (Agaricomycetes) and its associated carbohydrate composition. International Journal of Medicinal Mushrooms. 2020; 22(9), 803–814.
- Yap, H.-Y. Y.; et al. Glycation inhibitory activity of the sclerotial extract of Lignosus rhinocerotis (Cooke) Ryvarden (Tiger Milk Mushroom). 2014; Natural Product Communications, 9(1), 1–2.
- Lee, S.S.; et al. Evaluation of the sub-acute toxicity of the sclerotium of Lignosus rhinocerus (Cooke), the Tiger Milk mushroom. Journal of Ethnopharmacology. 2011; 138(1), pp.192–200.
- Yap, Y.H.-Y.; et al. Assessment of Acute Dermal Toxicity of Lignosus rhinocerus TM02Ŵ (Agaricomycetes) Sclerotium and Its Potent Cold Water Extract (xLrŴ). International journal of medicinal mushrooms. 2025; 27(8), pp.81–93.
- Lee, S.S.; et al. Anti-inflammatory effect of the sclerotium of Lignosus rhinocerotis (Cooke) Ryvarden, the Tiger Milk mushroom. BMC Complementary and Alternative Medicine. 2014; 14(1).
- Lee, M.-K.; et al. Bronchodilator effects of Lignosus rhinocerotis extract on rat isolated airways is linked to the blockage of calcium entry. Phytomedicine. 2018; 42, pp.172–179.
- Poh, M.E.; et al. Polyporaceae Lignosus Rhinocerus TM02® Cultivar as Complementary Therapy for Respiratory Health: A Preliminary Investigation of Asthma. Pharmacological Research. 2025; 9, p.100405
- Tan, H.-D.; et al. Clinical efficacy of TM02® in allergic rhinitis: Significant symptom alleviation associated with IL-5 downregulation and reduced allergic inflammation. Current Issues in Molecular Biology. 2026; 48(9):898.
- Eng, J.Y.; et al. Efficacy and safety of Lignosus rhinocerus (Cooke) Ryvarden TM02® supplementation for immune-challenged patients with localised breast cancer in remission: A randomised controlled trial. BMC Complementary Medicine and Therapies. 2025; 25(1).
- Chen, C.; et al. Combined effects of lignosus rhinocerotis supplementation and resistance training on isokinetic muscular strength and power, anaerobic and aerobic fitness level, and immune parameters in young males. International Journal of Preventive Medicine. 2016; 7(1), p.107.

